Combining spectroscopy: a new approach to meeting new pharmaceutical challenges
Automated image analysis has been combined with Raman spectroscopy to achieve component-specific size and shape analysis of active ingredients, supporting and accelerating the commercialization of both innovator and generic pharmaceutical products.
Ongoing changes within the pharmaceutical industry provide a strong stimulus for the development of new analytical tools, such as instruments that are more precise, faster or more informative than their predecessors. The drive for greater efficiency, for example – from drug discovery through to manufacture – creates a demand for instruments that can efficiently provide the insight needed for fast and effective product development, while simultaneously putting the spotlight on systems that can monitor in real-time to support process optimisation. The blossoming generics sector is similarly thirsty for knowledge, but understanding and providing equivalent pharmaceutical product performance is a significant challenge.